Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer type, with cases diagnosed annually worldwide.1,2 Surgical cancer resection remains the preferred treatment for HNSCC,3,4 where the surgeon balances two main challenges: (1) complete surgical resection and (2) preservation of nerves to reduce pain and maintain function. The most important factor for predicting long-term survival following surgery is the completeness of cancer resection.5 – 7 However, identifying tumors and normal tissues during surgery remains challenging, and positive surgical margins occur in 15% to 30% of patients, resulting in poor outcomes and additional therapy.8,9 Furthermore, additional malignancies are often present and undetected during surgery, representing the second leading cause of death in HNSCC patients.10 Secondary to cancer treatment, surgical outcomes are plagued by intraoperative nerve damage, causing lasting pain and loss of function, significantly affecting patient postoperative quality of life. Important cranial, spinal, and facial nerves are small, and translucent structures often buried within tissue, making them difficult to consistently identify and visualize, leading to nerve damage.11 – 14 As a result, a number of comorbidities, including severe pain, dysphagia, and jaw and sensory dysfunction, are experienced by of patients.15 Unfortunately, achieving complete cancer resection while simultaneously preserving important nerves in the head and neck region remains difficult, where efforts to preserve normal anatomy and function limit cancer resection margins. Thus, current intraoperative cancer and nerve detection techniques, generally consisting of preoperative imaging, biopsy, intraoperative neuromonitoring, and visual inspection, fall far short of meeting the clinical need.16